Conference Coverage
Latest News
SPF is only the start when recommending sunscreens
In a recent study, 43% of dermatologists who responded to a survey reported that they never, rarely, or only sometimes took a patient’s skin type...
Conference Coverage
Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’s
Results of a phase 3 trial in Chinese patients with systemic lupus erythematosus showed a significantly greater response rate with telitacicept,...
Conference Coverage
Two biologics show no difference in axial spondyloarthritis radiographic progression over 2 years
This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at...
Conference Coverage
Lupus nephritis: Hopes, questions arise for baricitinib
Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of...
Conference Coverage
Buprenorphine update: Looser rules and a helpful injectable
As overdose epidemic continues, new regulations change landscape for opioid addiction therapy.
Conference Coverage
ILD risk elevated in RA, PsA after starting biologic or targeted synthetic DMARDs
The risk for interstitial lung disease in patients with PsA during the first 5 years after starting a biologic or targeted synthetic DMARD was...
Conference Coverage
Family placement better for deprived kids than institutions
“Being placed in a family reduced the symptoms of reactive attachment disorder to pretty much nonexistent,” said Dr. Kathryn Humphreys.
Conference Coverage
Significant increase in vitamin D deficiency in kids with major depressive disorder
The findings reiterate the importance of screening for vitamin D deficiency in children and adolescents, with or without depression.
Conference Coverage
New treatments under study for celiac disease
Investigational treatment found to be highly effective in blocking gluten-specific T cells in celiac disease.
Conference Coverage
Multiple successive biologic to biosimilar switches deemed safe and effective
Triple switching from infliximab biologic to biosimilar for IBD found no new safety or efficacy concerns.
Conference Coverage
Few patients take weight control medications after bariatric surgery
Weight control medications may be needed to prevent weight regain.